Abstract
AbstractImportanceRates of prenatal cannabis exposure (PCE) are rising with increasingly permissive legislation regarding cannabis use, which may be a risk factor for psychosis. Disrupted reward-related neural circuitry may underlie this relationship.ObjectiveTo elucidate neural mechanisms involved in the association between PCE and youth-onset psychotic-like experiences by probing correlates of reward anticipation, a neurobehavioral marker of endocannabinoid-mediated dopaminergic function.Design, setting, and participantsThis longitudinal, prospective study analyzed task-related functional neuroimaging data from baseline (n=11,368), 2-year follow-up (n=7,928), and 4-year follow-up (n=2,982) of the ongoing Adolescent Brain and Cognitive Development (ABCD) Study, which recruited children aged 9 to 10 years old at baseline from 22 sites across the United States.ResultsPCE (n=652 exposed youth) is longitudinally associated with psychotic-like experiences. Blunted neural response to reward anticipation is associated with psychotic-like experiences, with stronger effects observed in PCE youth (all |β| > 0.5; false discovery rate [FDR]–correctedP< .05). This hypoactivation at baseline predicts psychosis symptomatology in middle adolescence (4-year follow-up visit; β=-.004; FDR-correctedP< .05). Dampened behavioral reward sensitivity is associated with psychotic-like experiences across baseline, 2-year follow-up visit, and 4-year follow-up visit (|β| = .21; FDR-correctedP< .001). Psychotic-like experiences are positively associated with trait-level measures of reward motivation and impulsivity, with stronger effects for PCE youth (all |β| > 0.1; all FDR-correctedP< .05).Conclusions and RelevanceBlunted activation in reward-related brain regions may serve as a biomarker for disrupted reward processing and increased psychosis risk during development. PCE may affect childhood behaviors and traits related to altered reward sensitivity.
Publisher
Cold Spring Harbor Laboratory
Reference63 articles.
1. 2022 NSDUH Detailed Tables | CBHSQ Data. Accessed June 14, 2024. https://www.samhsa.gov/data/report/2022-nsduh-detailed-tables
2. Results from the 2021 National Survey on Drug Use and Health (NSDUH): Key Substance Use and Mental Health Indicators in the United States | SAMHSA Publications and Digital Products. Accessed June 14, 2024. https://store.samhsa.gov/product/results-2021-national-survey-drug-use-and-health-nsduh-key-substance-use-and-mental-health
3. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
4. Cannabis use and psychosis: a review of reviews
5. Cannabis Use and the Course of Schizophrenia: 10-Year Follow-Up After First Hospitalization